Trial Profile
Phase 1 Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Aug 2018
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary) ; Maraviroc (Primary)
- Indications HIV infections
- Focus Adverse reactions; First in man; Pharmacokinetics
- 06 Mar 2014 Results presented at the 21st Conference on Retroviruses and Opportunistic Infections.
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2012 Planned End Date changed from 1 Apr 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.